Found 41 clinical trials
Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes. (KIC-START)
This study is expected to contribute to the body of real-world data of tofacitinib's safety and efficacy profile in ulcerative colitis. Conventional clinical outcomes will give a better understanding of response and remission rates in a representative, post-marketing population. Regular patient questionnaires and measurement of a biomarker of gut inflammation …
- 0 views
- 05 Apr, 2023
- 2 locations
Microbiota Analysis to Predict Outcomes of Rheumatoid Arthritis Patients Treated With JAK-inhibitor (MARAJA)
. Three are currently available: upadacitinib (UPA) tofacitinib and baricitinib. Our study will focus on UPA. Clinical outcomes mainly depend on i) factors influencing drug metabolism & concentrations
- 0 views
- 23 Mar, 2022
- 1 location
Prediction Model for Response to Biologics and Small Molecular Agent for UC
This prospective observational study is going to develop and validate a prediction model of response to biologic agents and small molecular agents for Korean patients with ulcerative colitis.
- 0 views
- 23 Mar, 2022
- 1 location
Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice
This is a Multinational Study of Tofacitinib in Patients Treated for Psoriatic Arthritis in order to evaluate the effectiveness of treatment with tofacitinib on disease activity, remission, and
- 0 views
- 08 Apr, 2023
- 14 locations
Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis (ESCALATE-RA)
Tofacitinib in a real world setting.
- 16 views
- 10 Apr, 2023
- 42 locations
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
Janus kinase (JAK) inhibitors are a new class of molecules available to the therapeutic arsenal for chronic inflammatory rheumatic diseases.The tolerance profile of this new class needs to be better defined and its use in real life further established. The French Society of Rheumatologists intends to coordinate a prospective national …
- 3 views
- 05 Aug, 2021
- 57 locations
Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy (RETUCAS)
Tofacitinib (TOFA) is a JAK inhibitor already used in rheumatology for the treatment of moderate-to-severe active rheumatoid arthritis and psoriatic arthritis in adult patients who have
- 0 views
- 09 Jul, 2022
- 1 location
Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis (TOFAST)
This is an observational prospective study with two years of follow-up, designed to evaluate the effectiveness of tofacitinib in patients with moderate to severe ulcerative colitis in French
- 0 views
- 08 Apr, 2023
- 34 locations
A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis
that can also affect the skin, nails and eyes. The study medicine is called Tofacitinib. This study is seeking participants who: Started taking tofacitinib alone or with other approved
- 0 views
- 10 Apr, 2023
Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden (ODEN)
tofacitinib on clinical disease activity parameters in patients with ulcerative colitis in Swedish clinical practice. The study will also assess treatment adherence of tofacitinib using the Swedish Prescribed
- 92 views
- 11 Apr, 2023
- 13 locations